BSX — Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.

Sector

Healthcare

Industry

Medical - Devices

Market Cap

$92.00B

P/E Ratio

31.81

Beta

0.70

52-Week Range

61.25-109.5

Dividend Yield

$0.00

CEO

Michael F. Mahoney

Employees

53,000

IPO Date

May 19, 1992

Exchange

NYSE